Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Another Buying Opportunity .....SHAME on.... corrected maths

A whopping 1,334,700 shares OWNED by the company leadership. At 407.8M shares outstanding, our "leaders" own 0.003% of the outstanding shares. REMARKABLE

Please multiply by 100 lambertslunatics!!!!!

Share
New Message
Please login to post a reply